Observational assessment of safety in seroquel (OASIS): a specialist cohort event monitoring (SCEM) study in England
Background: This study was designed to monitor the short-term (up to 12 weeks) use and safety of quetiapine (Seroquel) extended release (XL) and quetiapine immediate release (IR) prescribed to patients with a clinical diagnosis of schizophrenia, and/or manic episodes associated with bipolar disorder...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
SAGE Publishing,
2020-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|